Aventiv Research offers clinical trials in Columbus on meningococcal disease, or meningitis, to discover advances in medical knowledge and prevention of the disease. Typically, young adults aged 18-25 receive a vaccine for meningitis before going into college and living in a dorm.
Meningitis is a serious illness, and is caused by specific types of bacteria that can make adolescents and young adults incredibly sick. The disease causes the tissues surrounding the brain and spinal cord to become inflamed and swollen. It spreads via coughing, sneezing, kissing, or even sharing a beverage with someone who has the bacteria.
There are different types of meningococcal disease; the 5 main types are A, B, C, W, and Y. There are specific vaccines for types A, C, W, and Y, and separate vaccines for type B. As of right now, there is no single vaccine that prevents all types of meningitis, which is why the MEMENTO 057 trial was created.
The MEMENTO 057 trial was designed to help doctors understand if the investigational vaccine for MenABCWY, as a single vaccine, works the same and is as safe as giving the components as two separate vaccines Trumenba (MnB) and Menveo (MenACWY-CRM). The trial will also help doctors learn whether a 2-shot series of Trumenba works and is safe.
There are several benefits associated with participating in meningitis clinical trial:
In addition, you’ll be providing valuable research for doctors studying the disease and developing improvements for our current vaccinations.
If you’re interested in signing up for the MEMENTO 057 clinical trial, fill in the form below. If you have questions or concerns, please contact us today at 614-501-6164 to find out more.
This is a great way to make extra money and be involved in a research study that will help and benefit many people to come. I’ve really enjoyed myself with the program and with the staff.
"Thank you for your courtesy and kindness. I felt confident and comfortable. I would recommend the research study here. My coordinator was awesome and very caring."
Any stigma or hesitation about clinical research should be disregarded. A good learning program for research studies.
It's a good way to find out if there's some new drugs that can help people that have problems like mine and the people here are just wonderful to work with.